Cash flow GE Aerospace CBOE

Stocks

GE

US3696043013

Aerospace & Defense

Market Closed - CBOE 03:59:42 12/09/2026 HKT			5-day change	1st Jan Change
323.62 ^USD	-0.10%		-2.86%	+5.14%

06:10pm	GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports	RE
09-11	TransMedics Names Fernando Araujo as CFO; Maintains 2026 Revenue Outlook	MT

2a8f051fd72ec.rATUmg9_OhyuasJ0WKPh4Rv20Q1sJYMv5nCOYey9r7k.-jyat0ZGUnfmE7BNN-iCoC3P4Vo2Q_Ju0kX8Cb6Q-I32MOLbfjZ7VuMwoQ

Published financial data: GE AEROSPACE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	71.09B	73.6B	64.56B	35.12B	42.32B
Finance Div. Revenues	-	-	-	-	-
Insurance Division Revenues	3.11B	2.95B	3.39B	3.58B	3.53B
Gain (Loss) on Sale of Assets, Total (Rev)	-	-	-	-	-
Interest And Invest. Income (Rev)	-	-	-	-	-
Other Revenues, Total	-	-1M	-	-	-
Total Revenues	74.2B	76.56B	67.95B	38.7B	45.86B
Cost of Goods Sold, Total	53.5B	55.28B	50.24B	24.28B	28.96B
Finance Div. Operating Exp.	-	-	-	-	-
Insurance Division Operating Expenses, Total	2.28B	2.73B	2.89B	2.43B	2.45B
Interest Expense - Finance Division	-	-	-	-	-
Gross Profit	18.41B	18.54B	14.83B	11.99B	14.44B
Selling General & Admin Expenses, Total	13.21B	10.81B	7.13B	2.95B	3.38B
R&D Expenses	2.5B	2.81B	1.91B	1.29B	1.58B
Other Operating Expenses, Total	15.71B	13.63B	9.04B	4.24B	4.96B
Operating Income	2.7B	4.91B	5.8B	7.76B	9.48B
Interest Expense, Total	-1.88B	-1.61B	-1.12B	-986M	-843M
Interest And Investment Income	621M	456M	739M	813M	946M
Net Interest Expenses	-1.26B	-1.15B	-379M	-173M	103M
Income (Loss) On Equity Invest.	-96M	233M	237M	173M	216M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	698M	562M	338M	235M	289M
EBT, Excl. Unusual Items	2.05B	4.55B	5.99B	7.99B	10.09B
Restructuring Charges	-818M	-1.97B	-1.68B	-1.04B	-118M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-251M	-
Gain (Loss) On Sale Of Investments	1.65B	47M	5.78B	518M	21M
Gain (Loss) On Sale Of Assets	-40M	-	-	347M	-
Asset Writedown	-	-824M	-	-	-
Other Unusual Items	-6.52B	-399M	104M	52M	6M
EBT, Incl. Unusual Items	-3.68B	1.41B	10.19B	7.62B	10B
Income Tax Expense	-286M	476M	1.16B	962M	1.4B
Earnings From Continuing Operations	-3.4B	936M	9.03B	6.66B	8.6B
Earnings Of Discontinued Operations	-3.2B	-644M	414M	-91M	103M
Net Income to Company	-6.59B	292M	9.44B	6.57B	8.7B
Minority Interest	71M	-67M	37M	-11M	6M
Net Income - (IS)	-6.52B	225M	9.48B	6.56B	8.7B
Preferred Dividend and Other Adjustments	246M	285M	295M	-	-
Net Income to Common Incl Extra Items	-6.77B	-60M	9.19B	6.56B	8.7B
Net Income to Common Excl. Extra Items	-3.57B	584M	8.77B	6.65B	8.6B
Per Share Items
Net EPS - Basic	-6.16	-0.05	8.44	6.04	8.2
Basic EPS - Continuing Operations	-3.25	0.53	8.06	6.13	8.11
Basic Weighted Average Shares Outstanding	1.1B	1.1B	1.09B	1.08B	1.06B
Net EPS - Diluted	-6.16	-0.05	8.36	5.99	8.15
Diluted EPS - Continuing Operations	-3.25	0.53	7.98	6.07	8.05
Diluted Weighted Average Shares Outstanding	1.1B	1.1B	1.1B	1.09B	1.07B
Normalized Basic EPS	1.23	2.54	3.47	4.59	5.95
Normalized Diluted EPS	1.23	2.52	3.44	4.56	5.91
Dividend Per Share	0.32	0.32	0.32	1.12	1.44
Payout Ratio	-8.82	284	6.21	15.38	16.68
American Depositary Receipts Ratio (ADR)	0.05	0.05	0.05	0.05	0.05
Supplemental Items
EBITDA	5.71B	7.63B	7.88B	8.94B	10.7B
EBITA	3.84B	5.89B	6.4B	8.11B	9.84B
EBIT	2.7B	4.91B	5.8B	7.76B	9.48B
EBITDAR	6.79B	8.68B	8.7B	9.42B	11.09B
Total Revenues (As Reported)	74.2B	76.56B	67.95B	38.7B	45.86B
Effective Tax Rate - (Ratio)	7.77	33.71	11.4	12.62	14.05
Current Domestic Taxes	-1.43B	66M	-283M	358M	599M
Current Foreign Taxes	1.15B	1.04B	823M	423M	709M
Total Current Taxes	-278M	1.11B	540M	781M	1.31B
Deferred Domestic Taxes	-617M	-1.1B	32M	122M	65M
Deferred Foreign Taxes	608M	466M	591M	59M	32M
Total Deferred Taxes	-9M	-631M	623M	181M	97M
Normalized Net Income	1.35B	2.78B	3.78B	4.98B	6.31B
Interest Capitalized	-	-	-	-	-
Non-Cash Pension Expense	2.08B	-128M	-1.36B	-755M	-718M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	2.5B	2.81B	1.91B	1.29B	1.58B
Net Rental Expense, Total	1.08B	1.06B	820M	482M	385M
Imputed Operating Lease Interest Expense	461M	536M	299M	180M	124M
Imputed Operating Lease Depreciation	620M	519M	521M	302M	261M
Stock-Based Comp., Other (Total)	370M	322M	360M	438M	490M
Total Stock-Based Compensation	370M	322M	360M	438M	490M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	13.47B	14.16B	14.87B	13.22B	11.99B
Short Term Investments	12.3B	7.61B	5.71B	982M	-
Total Cash And Short Term Investments	25.77B	21.77B	20.57B	14.2B	11.99B
Accounts Receivable, Total	16.89B	18.47B	14.45B	11.37B	14.01B
Other Receivables	3.44B	2.34B	2.09B	862M	881M
Total Receivables	20.33B	20.81B	16.54B	12.24B	14.89B
Inventory	15.85B	17.4B	16.53B	9.76B	11.87B
Prepaid Expenses	341M	395M	248M	-	-
Finance Division Loans and Leases Current	-	-	-	-	-
Finance Division Other Current Assets, Total	-	-	-	-	-
Restricted Cash	2.38B	3.1B	2.1B	400M	400M
Other Current Assets, Total	1.69B	2.76B	3.81B	1.04B	1.45B
Total Current Assets	66.35B	66.23B	59.8B	37.64B	40.6B
Gross Property Plant And Equipment	34.51B	33.77B	29.17B	16.95B	18.41B
Accumulated Depreciation	-18.9B	-19.29B	-16.68B	-9.67B	-10.42B
Net Property Plant And Equipment	15.61B	14.48B	12.49B	7.28B	7.99B
Long-term Investments	50.05B	44.6B	45.93B	43.99B	45.9B
Goodwill	26.18B	25.8B	13.38B	8.54B	9.06B
Other Intangibles, Total	9.33B	7.62B	5.7B	4.26B	4.22B
Finance Division Loans and Leases Long-Term	-	-	-	-	-
Finance Division Other Long-Term Assets, Total	-	-	-	-	-
Accounts Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	10.86B	11.7B	10.58B	7.11B	7.46B
Deferred Charges Long-Term	2.55B	2.56B	2.46B	2.44B	2.42B
Other Long-Term Assets, Total	17.95B	14.78B	12.7B	11.9B	12.52B
Total Assets	199B	188B	163B	123B	130B
Liabilities
Accounts Payable, Total	16.24B	18.64B	10.68B	6.25B	5.73B
Accrued Expenses, Total	10.98B	7B	10.68B	3.48B	4.04B
Short-term Borrowings	97M	124M	102M	-	25M
Current Portion of Long-Term Debt	2.89B	2.44B	1.15B	2.04B	1.66B
Current Portion of Leases	-	-	-	283M	280M
Finance Division Debt Current	1.37B	1.19B	-	-	-
Finance Division Other Current Liabilities, Total	-	-	-	-	-
Current Income Taxes Payable	500M	743M	654M	-	-
Unearned Revenue Current, Total	17.37B	18.12B	19.68B	16.05B	18B
Other Current Liabilities	2.5B	8.69B	7.93B	6.29B	9.25B
Total Current Liabilities	51.95B	56.95B	50.88B	34.39B	38.98B
Long-Term Debt	17.55B	22.3B	19.71B	17.23B	18.81B
Long-Term Leases	2.85B	2.39B	1.97B	822M	783M
Finance Division Debt Non Current	13.27B	6.29B	-	-	-
Finance Division Other Non Current Liabilities, Total	37.17B	33.35B	39.62B	36.21B	36.89B
Unearned Revenue Non Current	1.99B	2.01B	1.34B	1.01B	1.06B
Other Non Current Liabilities	32.48B	26.92B	20.94B	13.9B	14.74B
Total Liabilities	157B	150B	134B	104B	111B
Preferred Stock Redeemable	6M	6M	-	-	-
Total Preferred Equity	6M	6M	-	-	-
Common Stock, Total	15M	15M	15M	15M	15M
Retained Earnings	85.11B	84.69B	86.53B	80.49B	87.66B
Treasury Stock	-81.09B	-81.21B	-79.98B	-81.57B	-87.8B
Comprehensive Income and Other	36.27B	32.86B	20.81B	20.4B	18.8B
Total Common Equity	40.3B	36.36B	27.38B	19.34B	18.68B
Minority Interest	1.3B	1.22B	1.2B	223M	221M
Total Equity	41.61B	37.58B	28.58B	19.56B	18.9B
Total Liabilities And Equity	199B	188B	163B	123B	130B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.1B	1.09B	1.09B	1.07B	1.05B
ECS Total Common Shares Outstanding	1.1B	1.09B	1.09B	1.07B	1.05B
Book Value / Share	36.67	33.39	25.15	18.01	17.81
Tangible Book Value	4.79B	2.94B	8.3B	6.55B	5.39B
Tangible Book Value Per Share	4.36	2.7	7.62	6.1	5.14
Total Debt	38.03B	34.74B	22.94B	20.38B	21.56B
Net Debt	12.27B	12.97B	2.36B	6.18B	9.56B
Debt Equivalent of Unfunded Proj. Benefit Obligation	11.08B	7.85B	6.09B	4.35B	4.3B
Debt Equivalent Oper. Leases	8.65B	8.44B	6.56B	3.86B	3.08B
Minority Interest, Total (Incl. Fin. Div)	1.3B	1.22B	1.2B	223M	221M
Equity Method Investments, Total	7.39B	-	7.93B	6.25B	7.12B
Account Code - Inventory Valuation	5	5	4	6	6
Inventories - Raw Materials, Total	8.71B	10.36B	11.21B	7.37B	9.35B
Inventories - Finished Goods, Total	4.93B	5.03B	3.72B	1.46B	1.54B
Inventories - Others	2.21B	2.02B	1.6B	932M	972M
Land - (BS)	585M	542M	482M	131M	139M
Buildings, Total	8.31B	7.91B	6.34B	3.15B	3.3B
Machinery, Total	21.04B	21.12B	19B	11.53B	12.76B
Full Time Employees	168K	172K	125K	53K	57K
Accumulated Allowance for Doubtful Accounts (Supple)	1.07B	859M	647M	106M	94M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-6.52B	225M	9.48B	6.56B	8.7B
Depreciation & Amortization - CF	1.87B	1.74B	1.47B	834M	863M
Amortization of Goodwill and Intangible Assets - (CF)	1.14B	977M	606M	350M	357M
Depreciation & Amortization, Total	3.01B	2.72B	2.08B	1.18B	1.22B
Minority Interest in Earnings - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	170M	59M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-1.66B	144M	-5.84B	-719M	-292M
Asset Writedown & Restructuring Costs	-	765M	-	251M	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-216M
Net Cash From Discontinued Operations	2.44B	52M	-391M	-1.11B	-6M
Other Operating Activities, Total	6.79B	555M	-1.79B	-758M	-403M
Change In Accounts Receivable	854M	-1.55B	450M	-1.19B	-2.95B
Change In Inventories	-702M	-2.34B	-1.52B	-1.53B	-1.98B
Change In Accounts Payable	-2M	2.79B	-221M	688M	1.99B
Change in Unearned Revenues	-1.05B	2.49B	2.93B	1.6B	1.9B
Change in Other Net Operating Assets	-	-	-	-266M	562M
Cash from Operations	3.33B	5.92B	5.18B	4.71B	8.54B
Capital Expenditure	-1.25B	-1.37B	-1.6B	-1.03B	-1.27B
Sale of Property, Plant, and Equipment	167M	209M	89M	114M	123M
Cash Acquisitions	-1.55B	-30M	-365M	-135M	-360M
Divestitures	26.5B	4.73B	9B	5.75B	-
Sale (Purchase) of Intangible assets	-111M	-113M	-	-	-
Investment in Marketable and Equity Securities, Total	-1.29B	-876M	-986M	-963M	425M
Other Investing Activities, Total	-1.16B	-281M	-2.17B	-5.4B	-68M
Cash from Investing	21.31B	2.27B	3.98B	-1.67B	-1.15B
Short Term Debt Issued, Total	-	65M	-	2M	25M
Long-Term Debt Issued, Total	364M	8.2B	11M	-	1.98B
Total Debt Issued	364M	8.27B	11M	2M	2.01B
Short Term Debt Repaid, Total	-710M	-	-55M	-	-
Long-Term Debt Repaid, Total	-36.52B	-11.2B	-3.36B	-788M	-1.81B
Total Debt Repaid	-37.23B	-11.2B	-3.42B	-788M	-1.81B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-1.05B	-1.23B	-5.83B	-7.55B
Repurchase of Preferred Stock	-	-	-5.8B	-	-
Common Dividends Paid	-	-	-	-1.01B	-1.45B
Common & Preferred Stock Dividends Paid	-575M	-639M	-589M	-	-
Common & Preferred Stock Dividends Paid	-575M	-639M	-589M	-1.01B	-1.45B
Other Financing Activities, Total	-7.74B	-963M	2.41B	895M	122M
Cash from Financing	-45.18B	-5.58B	-8.61B	-6.73B	-8.68B
Foreign Exchange Rate Adjustments	-213M	-369M	120M	-193M	201M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-1M
Net Change in Cash	-20.75B	2.23B	663M	-3.88B	-1.1B
Supplemental Items
Cash Interest Paid	2.54B	1.56B	1.07B	969M	882M
Cash Income Tax Paid (Refund)	1.16B	1.13B	1.15B	334M	739M
Levered Free Cash Flow	1.23B	2.86B	3.44B	4.42B	5.21B
Unlevered Free Cash Flow	2.4B	3.86B	4.14B	5.03B	5.74B
Change In Net Working Capital	1.3B	766M	327M	405M	626M
Net Debt Issued / Repaid	-36.87B	-2.94B	-3.4B	-786M	199M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	0.74	1.59	2.06	3.27	4.68
Return on Total Capital	1.73	4.04	6.44	10.74	14.74
Return On Equity %	-8.63	2.36	28.44	27.64	44.69
Return on Common Equity	-9.42	1.52	28.73	28.44	45.25
Margin Analysis
Gross Profit Margin %	24.81	24.21	21.83	30.99	31.5
SG&A Margin	17.8	14.12	10.49	7.62	7.37
EBITDA Margin %	7.7	9.97	11.59	23.1	23.34
EBITA Margin %	5.18	7.69	9.42	20.95	21.46
EBIT Margin %	3.64	6.41	8.53	20.04	20.68
Income From Continuing Operations Margin %	-4.58	1.22	13.29	17.2	18.74
Net Income Margin %	-8.79	0.29	13.95	16.94	18.98
Net Avail. For Common Margin %	-4.81	0.76	12.91	17.17	18.76
Normalized Net Income Margin	1.82	3.63	5.57	12.88	13.77
Levered Free Cash Flow Margin	1.66	3.73	5.07	11.41	11.36
Unlevered Free Cash Flow Margin	3.24	5.04	6.09	13	12.51
Asset Turnover
Asset Turnover	0.33	0.4	0.39	0.26	0.36
Fixed Assets Turnover	4.59	5.09	5.51	5.33	6.01
Receivables Turnover (Average Receivables)	4.07	4.03	4.41	3.23	3.33
Inventory Turnover (Average Inventory)	3.37	3.33	3.2	2.69	2.68
Short Term Liquidity
Current Ratio	1.28	1.16	1.18	1.09	1.04
Quick Ratio	0.89	0.75	0.73	0.77	0.69
Operating Cash Flow to Current Liabilities	0.06	0.1	0.1	0.14	0.22
Days Sales Outstanding (Average Receivables)	89.71	90.56	82.77	113.42	109.46
Days Outstanding Inventory (Average Inventory)	108.26	109.76	114.14	136.02	136.3
Average Days Payable Outstanding	111.64	112.01	72.87	82	60.49
Cash Conversion Cycle (Average Days)	86.33	88.31	124.04	167.43	185.27
Long Term Solvency
Total Debt/Equity	91.4	92.45	80.26	104.16	114.07
Total Debt / Total Capital	47.75	48.04	44.52	51.02	53.29
LT Debt/Equity	80.92	82.45	75.87	92.29	103.67
Long-Term Debt / Total Capital	42.28	42.84	42.09	45.2	48.43
Total Liabilities / Total Assets	79.08	79.99	82.47	84.11	85.48
EBIT / Interest Expense	1.44	3.06	5.19	7.87	11.25
EBITDA / Interest Expense	3.62	5.4	7.78	9.56	13.15
(EBITDA - Capex) / Interest Expense	2.96	4.55	6.35	8.51	11.64
Total Debt / EBITDA	5.6	4	2.64	2.16	1.94
Net Debt / EBITDA	1.81	1.49	0.27	0.66	0.86
Total Debt / (EBITDA - Capex)	6.86	4.75	3.23	2.43	2.2
Net Debt / (EBITDA - Capex)	2.21	1.77	0.33	0.74	0.97
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.16	3.18	16.96	9.49	18.48
Gross Profit, 1 Yr. Growth %	14.1	1.38	29.64	25.79	20.45
EBITDA, 1 Yr. Growth %	110.11	33.56	78.05	20.43	19.71
EBITA, 1 Yr. Growth %	550.08	53.23	119.39	22.33	21.38
EBIT, 1 Yr. Growth %	-527.85	81.58	147.14	24.21	22.25
Earnings From Cont. Operations, 1 Yr. Growth %	-152.59	-127.56	-1.23K	-29.53	29.09
Net Income, 1 Yr. Growth %	-214.31	-103.45	2.7K	-30.86	32.76
Normalized Net Income, 1 Yr. Growth %	-253.17	105.43	229.91	37.96	26.66
Diluted EPS Before Extra, 1 Yr. Growth %	-159.57	-116.3	-861.85	-27.38	32.56
Accounts Receivable, 1 Yr. Growth %	-6.5	2.32	-2.52	9.44	23.17
Inventory, 1 Yr. Growth %	-0.27	9.82	10.99	17.85	21.56
Net Property, Plant and Equip., 1 Yr. Growth %	-6.53	-7.25	2.48	0.43	9.76
Total Assets, 1 Yr. Growth %	-22.38	-5.57	-13.66	-28.94	5.71
Tangible Book Value, 1 Yr. Growth %	1.27K	-38.71	-43.11	-52.6	-17.64
Common Equity, 1 Yr. Growth %	13.39	-9.79	-18.74	-29.42	-3.44
Cash From Operations, 1 Yr. Growth %	-6.61	77.55	-12.46	-9.23	81.25
Capital Expenditures, 1 Yr. Growth %	-20.84	9.68	35.86	19.72	23.35
Levered Free Cash Flow, 1 Yr. Growth %	-95.94	-19.14	96.34	108.84	8.18
Unlevered Free Cash Flow, 1 Yr. Growth %	-92.4	-17.94	54.72	82.48	5.61
Dividend Per Share, 1 Yr. Growth %	0	0	0	250	28.57
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-9.31	0.47	9.7	15.25	13.9
Gross Profit, 2 Yr. CAGR %	-9.46	7.59	14.75	25.82	23.09
EBITDA, 2 Yr. CAGR %	-10.26	64.14	85.47	31.57	20.07
EBITA, 2 Yr. CAGR %	-13	189.17	209.63	37.01	21.85
EBIT, 2 Yr. CAGR %	-12.76	178.73	810.1	39.59	23.23
Earnings From Cont. Operations, 2 Yr. CAGR %	136.53	-61.93	35.21	121.91	-4.62
Net Income, 2 Yr. CAGR %	14.43	-80.14	22.32	341.72	-4.19
Normalized Net Income, 2 Yr. CAGR %	0.85	77.39	2.72K	64.42	32.19
Diluted EPS Before Extra, 2 Yr. CAGR %	76.57	-68.84	30.83	158.06	-1.88
Accounts Receivable, 2 Yr. CAGR %	-6	1.13	-10.52	-12.42	16.1
Inventory, 2 Yr. CAGR %	-4.06	4.65	2.13	-19.03	19.69
Net Property, Plant and Equip., 2 Yr. CAGR %	-41.67	-6.89	-10.53	-22.74	4.99
Total Assets, 2 Yr. CAGR %	-13.4	-14.39	-9.46	-19.25	-13.33
Tangible Book Value, 2 Yr. CAGR %	-27.34	189.27	31.59	-33	-37.52
Common Equity, 2 Yr. CAGR %	19.32	1.14	-17.58	-24.23	-17.44
Cash From Operations, 2 Yr. CAGR %	-38.23	28.77	21.98	-10.78	28.27
Capital Expenditures, 2 Yr. CAGR %	-24.89	-6.82	19.71	24.86	21.52
Levered Free Cash Flow, 2 Yr. CAGR %	-85.19	-69.38	57.56	36.91	56.97
Unlevered Free Cash Flow, 2 Yr. CAGR %	-79.65	-65.13	28.56	25.55	44.23
Dividend Per Share, 2 Yr. CAGR %	0	0	0	87.08	112.13
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-8.55	-5.33	-3.59	-11.83	16.32
Gross Profit, 3 Yr. CAGR %	-5.15	-6.2	-2.52	2.11	24
EBITDA, 3 Yr. CAGR %	-23.71	2.46	40.63	57.46	27.49
EBITA, 3 Yr. CAGR %	-23.09	5.06	108.75	129.81	31.58
EBIT, 3 Yr. CAGR %	-26.14	11.39	109.34	380.32	33.55
Earnings From Cont. Operations, 3 Yr. CAGR %	-45.59	15.53	11.83	10.47	85.25
Net Income, 3 Yr. CAGR %	-33.68	-64.38	18.46	1.14	195.89
Normalized Net Income, 3 Yr. CAGR %	-15.08	27.84	62.4	916.16	50.72
Diluted EPS Before Extra, 3 Yr. CAGR %	-45.2	-20.21	13.48	9.21	106.67
Accounts Receivable, 3 Yr. CAGR %	18.8	-1.13	-7.16	-14.27	-1.88
Inventory, 3 Yr. CAGR %	4.71	0.36	1.32	-14.91	-7.28
Net Property, Plant and Equip., 3 Yr. CAGR %	-29	-31.92	-9.22	-22.46	-13.15
Total Assets, 3 Yr. CAGR %	-13.85	-10.87	-13.99	-14.77	-11.67
Tangible Book Value, 3 Yr. CAGR %	-31.91	-31.35	187	10.96	-28.23
Common Equity, 3 Yr. CAGR %	9.17	8.7	-8.34	-21.71	-17.85
Cash From Operations, 3 Yr. CAGR %	-12.53	-12.18	13.22	10.6	13
Capital Expenditures, 3 Yr. CAGR %	-42.65	-14.79	0.34	-2.49	24.35
Levered Free Cash Flow, 3 Yr. CAGR %	-50.95	-62.96	-51.66	47.14	30.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	-35.43	-59.49	-49.29	26.18	21.58
Dividend Per Share, 3 Yr. CAGR %	-52.36	0	0	51.83	65.1
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-9.09	-5.07	-6.87	-15.57	-9.57
Gross Profit, 5 Yr. CAGR %	-5.62	21.12	-7.22	-11.8	-2.04
EBITDA, 5 Yr. CAGR %	-19.54	55.1	-9.35	4.74	30.46
EBITA, 5 Yr. CAGR %	-20.3	11.07	-5.38	9.82	69.47
EBIT, 5 Yr. CAGR %	-22.82	-1.68	-2.88	16.9	71.89
Earnings From Cont. Operations, 5 Yr. CAGR %	-16.09	-35.73	-15.6	61.45	5.89
Net Income, 5 Yr. CAGR %	-2.76	-51.61	-15.76	5.66	8.82
Normalized Net Income, 5 Yr. CAGR %	-21.29	-9.96	11.36	30.24	48.19
Diluted EPS Before Extra, 5 Yr. CAGR %	-13.75	-41.89	-16.59	42.24	8.08
Accounts Receivable, 5 Yr. CAGR %	-6.85	-5.27	7.49	-9.86	-4.95
Inventory, 5 Yr. CAGR %	-6.57	-2.09	3.67	-10.72	-5.67
Net Property, Plant and Equip., 5 Yr. CAGR %	-20.93	-23.11	-22.12	-30.81	-13.71
Total Assets, 5 Yr. CAGR %	-11.44	-12.65	-12.12	-14.22	-12.67
Tangible Book Value, 5 Yr. CAGR %	-15.39	-42.86	-11.37	-6.33	72.7
Common Equity, 5 Yr. CAGR %	-11.87	-8.28	-2.44	-7.34	-12.08
Cash From Operations, 5 Yr. CAGR %	23.5	-2.03	0.79	-11.62	19.06
Capital Expenditures, 5 Yr. CAGR %	-29.54	-27.06	-24.79	-14.17	-4.22
Levered Free Cash Flow, 5 Yr. CAGR %	-58.93	-27	-19.9	-39.88	-29.75
Unlevered Free Cash Flow, 5 Yr. CAGR %	-53.16	-24.14	-14.25	-38.68	-28.98
Dividend Per Share, 5 Yr. CAGR %	-46.7	-45.61	-35.91	28.47	35.1